20
Curia Spain Sau, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Curia- A partner for the pharma and biotech industries to improve patient outcomes & quality of life.
One of their notable products is DEXAMETHASONE SODIUM PHOSPHATE, with a corresponding US DMF Number 29412.
Remarkably, this DMF maintains an Active status since its submission on June 01, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 23, 2015, and payment made on August 31, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II